Top Ten most popular articles on Pharmafile.com this week
August 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, biotech, drugs, healthcare, life sciences, medicines, pharma, pharmaceuticals, top ten
Another week passes by, and the headlines have seen some shocking stories, such as the news that the UK is …
Bristol-Myers Squibb’s $2.3 billion gamble to boost cancer pipeline
August 4, 2017Medical Communications, Sales and Marketing BMS, Bristol-Myers Squibb, IFM Therapeutics, biotech, drugs, pharma, pharmaceutical
Bristol-Myers Squibb has agreed a deal to acquire IFM Therapeutics for a potential $2.3 billion. The latter is a biotech …
NICE greenlights Celgene pancreatic cancer drug as first-line combination treatment
August 4, 2017Medical Communications, Sales and Marketing Cancer, Celgene, NICE, Pancreatic cancer, drugs, healthcare, life sciences, medicine, pharma, pharmaceuticals
Celgene is celebrating following NICE’s announcement that it had decided to recommend the use of nab-Paclitaxel, when used in combination …
Chan Zuckerberg Initiative injects $10 million into US big data healthcare project
August 4, 2017Medical Communications, Research and Development Big Data, Chan Zuckerberg initiative, biotech, drugs, healthcare, life sciences, medicine, pharma, pharmaceutical
Facebook CEO Mark Zuckerberg and philanthropist Priscilla Chan have continued their quest to improve worldwide healthcare with the latest donation …
Diabetes drug holds promise to slow Parkinson’s progression
August 4, 2017Medical Communications, Research and Development Parkinson's disease, biotech, diabetes, drugs, pharma, pharmaceutical
There are currently no treatments that are able to slow the development of Parkinson’s disease. This unmet medical need will …
Teva releases financials, shares fall off cliff, plans to axe 7000 jobs
August 3, 2017Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has released its second quarter financials and they do not make for great reading if you’re an investor. The …
FDA turns down Janssen’s sirukumab for rheumatoid arthritis
August 3, 2017Sales and Marketing FDA, Janssen, drugs, life sciences, medicine, pharma, pharmaceuticals, rheumatoid arthritis, sirukumab
Janssen has announced that it has suffered a knockback to its plans to commercialise sirukumab in the US in the …
Existing arthritis drug could save thousands in blood cancer treatment
August 3, 2017Research and Development University of Sheffield, arthritis, biotech, blood cancer, drugs, life sciences, medicine, pharma, pharmaceutical
Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer …
The common cold cured?
August 3, 2017Research and Development biotech, cold, drugs, pharma, pharmaceutical, rhinovirus
Researchers from Edinburgh Napier University have discovered a crucial step in bringing forward a cure for the common cold. The …
Gene editing carried out, distances ‘designer baby’ possibility
August 3, 2017Research and Development biotech, crispr, drugs, gene editing, pharma, pharmaceutical
The news broke last week that scientists in the US had carried out the first gene editing testing in the …
AstraZeneca’s Priority Review good news provides reprieve
August 2, 2017Sales and Marketing AstraZeneca, FDA, biotech, drugs, pharma, pharmaceutical
If there was a company that needed a series of good news stories this week, it was AstraZeneca. The blow …
Bicycle Therapeutics reveals new CFO
August 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, biotech, drugs, pharma, pharmaceutical
Bicycle Theapeutics, a biotech that is developing its bicyclic peptide product platform, has announced the appointed of Lee Kalowski as …
FDA approves Celgene and Agios’ acute myeloid leukaemia drug
August 2, 2017Research and Development, Sales and Marketing Celgene, FDA, Idhifa, acute myeloid leukaemia, agios, biotech, drugs, life sciences, medicines, pharma, pharmaceuticals
The FDA has given its approval for the commercialisation of Celgene and Agios Pharmaceutical’s Idhifa for the treatment of relapsed …
Record number of drug-related deaths, as opioid crisis hits UK
August 2, 2017Medical Communications, Research and Development biotech, drug deaths, drugs, fentanyl, opioid, pharma, pharmaceutical
Numbers released by the Office for National Statistics (ONC) has revealed that drug misuse deaths were at a record high, …
EMA reveals ‘business continuity plan’ for Brexit, cuts resources from non-essential areas
August 2, 2017Medical Communications, Research and Development EMA, brexit, drugs, life sciences, medicines, pharma, pharmaceutical
The uncertainty caused by Brexit has been and continues to be far-reaching, and perhaps most impactful for business, organisations and …
Daiichi settles undisclosed drug side-effects case for $300 million
August 2, 2017Research and Development, Sales and Marketing Benicar, Daiichi Sankyo, biotech, drugs, pharma, pharmaceutical
Daiichi Sankyo has settled a case alleging that it did not fully disclose adverse side-effects of its drug, Benicar, with …
Pfizer’s major drug doubles sales but overall revenue falls
August 1, 2017Research and Development, Sales and Marketing Bavencio, Pfizer, biotech, drugs, pharma, pharmaceutical, viagra
Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …
Biogen steal away Pfizer VP to boost R&D plans
August 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Pfizer, biotech, drugs, pharma, pharmaceutical
Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …
AstraZeneca scores second accelerated FDA review in 2 days for blood cancer drug
August 1, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, acalabrutinib, biotech, drugs, life sciences, pharma, pharmaceutical
It’s been a rollercoaster week for AstraZeneca.
New Lab-Grade Undercounter Refrigerators Use Redundant Cooling Technology to Maintain Optimal Storage Conditions
August 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical and laboratory personnel with the need to store vaccines, pharmaceuticals and other molecular or biological samples safely can benefit …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
